These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9916976)

  • 1. Rectally administered misoprostol for the treatment of postpartum hemorrhage unresponsive to oxytocin and ergometrine: a descriptive study.
    Ramsey PS; Ramin KD
    Obstet Gynecol; 1999 Jan; 93(1):157-8. PubMed ID: 9916976
    [No Abstract]   [Full Text] [Related]  

  • 2. Rectally administered misoprostol for the treatment of postpartum hemorrhage unresponsive to oxytocin and ergometrine: a descriptive study.
    O'Brien P; El-Refaey H; Gordon A; Geary M; Rodeck CH
    Obstet Gynecol; 1998 Aug; 92(2):212-4. PubMed ID: 9699753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rectal misoprostol for postpartum hemorrhage].
    Shojai R; Desbrière R; Dhifallah S; Courbière B; Ortega D; d'Ercole C; Boubli L
    Gynecol Obstet Fertil; 2004 Sep; 32(9):703-7. PubMed ID: 15380748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rectal administration of misoprostol for delivery induced hemorrhage. Preliminary study].
    Shojai R; Piéchon L; d'Ercole C; Boubli L; Pontiès JE
    J Gynecol Obstet Biol Reprod (Paris); 2001 Oct; 30(6):572-5. PubMed ID: 11883024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized study comparing rectally administered misoprostol versus syntometrine combined with an oxytocin infusion for the cessation of primary postpartum hemorrhage.
    Olufowobi O; Afnan M; Sorinola O; Papaioannou S; Sharif K
    Acta Obstet Gynecol Scand; 2002 Oct; 81(10):993; author reply 994. PubMed ID: 12366496
    [No Abstract]   [Full Text] [Related]  

  • 6. A randomized study comparing rectally administered misoprostol versus Syntometrine combined with an oxytocin infusion for the cessation of primary post partum hemorrhage.
    Lokugamage AU; Sullivan KR; Niculescu I; Tigere P; Onyangunga F; El Refaey H; Moodley J; Rodeck CH
    Acta Obstet Gynecol Scand; 2001 Sep; 80(9):835-9. PubMed ID: 11531635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of rectal misoprostol as second-line therapy for the treatment of primary postpartum hemorrhage.
    Baruah M; Cohn GM
    J Reprod Med; 2008 Mar; 53(3):203-6. PubMed ID: 18441726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rectal misoprostol versus intravenous oxytocin for the prevention of postpartum hemorrhage after vaginal delivery.
    Gerstenfeld TS; Wing DA
    Am J Obstet Gynecol; 2001 Oct; 185(4):878-82. PubMed ID: 11641670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized clinical trial comparing oral misoprostol with synthetic oxytocin or syntometrine in the third stage of labour.
    Cook CM; Spurrett B; Murray H
    Aust N Z J Obstet Gynaecol; 1999 Nov; 39(4):414-9. PubMed ID: 10687755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placebo-controlled randomized comparison of vaginal with rectal misoprostol in the prevention of postpartum hemorrhage.
    Ozkaya O; Sezik M; Kaya H; Desdicioglu R; Dittrich R
    J Obstet Gynaecol Res; 2005 Oct; 31(5):389-93. PubMed ID: 16176505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study between rectally administered misoprostol as a prophylaxis versus conventional intramuscular oxytocin in post partum hemorrhage.
    Haque N; Bilkis L; Haque N; Bari MS; Haque S
    Mymensingh Med J; 2009 Jan; 18(1 Suppl):S40-44. PubMed ID: 19377430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraumbilical injection of three different uterotonics in the management of retained placenta.
    Harara R; Hanafy S; Zidan MS; Alberry M
    J Obstet Gynaecol Res; 2011 Sep; 37(9):1203-7. PubMed ID: 21518127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of postpartum hemorrhage, safety and efficacy.
    Abu-Omar AA
    Saudi Med J; 2001 Dec; 22(12):1118-21. PubMed ID: 11802188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbetocin versus a combination of oxytocin and ergometrine in control of postpartum blood loss.
    Ngan L; Keong W; Martins R
    Int J Gynaecol Obstet; 2007 May; 97(2):152-3. PubMed ID: 17379220
    [No Abstract]   [Full Text] [Related]  

  • 15. Prospective study of intramuscular ergometrine compared with intramuscular oxytocin for prevention of postpartum hemorrhage.
    Saito K; Haruki A; Ishikawa H; Takahashi T; Nagase H; Koyama M; Endo M; Hirahara F
    J Obstet Gynaecol Res; 2007 Jun; 33(3):254-8. PubMed ID: 17578351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment for primary postpartum haemorrhage.
    Mousa HA; Alfirevic Z
    Cochrane Database Syst Rev; 2003; (1):CD003249. PubMed ID: 12535465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postpartum hemorrhage in the developed world: whither misoprostol?
    Gibbins KJ; Albright CM; Rouse DJ
    Am J Obstet Gynecol; 2013 Mar; 208(3):181-3. PubMed ID: 22901709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-partum haemorrhage: beyond the confrontation between misoprostol and oxytocin.
    Buekens P; Althabe F
    Lancet; 2010 Jan; 375(9710):176-8. PubMed ID: 20109901
    [No Abstract]   [Full Text] [Related]  

  • 19. Prophylactic syntometrine vs oxytocin in the third stage of labour.
    Anderson T
    Pract Midwife; 1998 Oct; 1(10):40-1. PubMed ID: 10026588
    [No Abstract]   [Full Text] [Related]  

  • 20. Misoprostol use in the community to reduce maternal death.
    Winikoff B; Blum J
    Lancet; 2010 Sep; 376(9745):954-5; author reply 955-6. PubMed ID: 20851251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.